Nippon India Pharma Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹217 Cr | ₹8161 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 08 Nov 2021 | 05 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
Turn Over | % | 21% |
Expense Ratio | 2.35 | 1.82 |
Manager | Rohan Korde | Sailesh Raj Bhan |
ISIN Code | INF00XX01BL5 | INF204K01968 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | 1.43% | 3.25% |
6 Month | -5.27% | -1.91% |
1 Year | 16.5% | 15.97% |
3 Year | 18.68% | 20.02% |
5 Year | - | 22.55% |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | -1.29% | 1.17% |
1 Year | 1.9% | 3.92% |
3 Year | 22.79% | 24.01% |
5 Year | - | 19.63% |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 22.47% | 18.19% |
3 Year | 18.57% | 20.5% |
5 Year | - | 20.36% |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | 15.667% | 15.623% |
Sharp | 0.739% | 0.707% |
Beta | 0.959% | 0.908% |
Alpha | -1.413% | 0.486% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Rohan Korde | Sailesh Raj Bhan |
Total AUM | ₹4626 Cr | ₹96086 Cr |
Funds Managed | 10 | 5 |
ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 7.57 | 1.36 |
Mid Cap | 31.22 | 32.78 |
Small Cap | 32.03 | 27.14 |
Large Cap | 29.19 | 38.72 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 8.42 | 1.36 |
Healthcare | 88.76 | 98.64 |
Basic Materials | 2.08 | - |
Industrials | 0.74 | - |
Financial Services | 0 | - |
Top Comparisons
ICICI Prudential Large & Mid Cap Fund - Growth
3Y Returns21.26%
Canara Robeco Emerging Equities - Regular Plan - Growth Option
3Y Returns15.62%
Axis Nifty 100 Index Fund - Regular Plan - Growth Option
3Y Returns12.62%
HSBC NIFTY NEXT 50 INDEX FUND - Regular Growth
3Y Returns14.4%
BANDHAN Sterling Value Fund - Regular Plan - Growth
3Y Returns16.66%
Tata Equity PE Fund Regular Plan -(Growth Option)
3Y Returns19.26%
Franklin India Flexi Cap Fund - Growth
3Y Returns19.08%
HSBC Flexi Cap Fund - Regular Growth
3Y Returns16.64%